Joy Benadiba
Centre Hospitalier Universitaire de Nice(FR)Hôpital l'Archet(FR)
Publications by Year
Research Areas
Blood groups and transfusion, Platelet Disorders and Treatments, Blood disorders and treatments, Immunodeficiency and Autoimmune Disorders, Childhood Cancer Survivors' Quality of Life
Most-Cited Works
- → L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia(2014)126 cited
- → Iron chelation: an adjuvant therapy to target metabolism, growth and survival of murine PTEN-deficient T lymphoma and human T lymphoblastic leukemia/lymphoma(2016)32 cited
- → PFMG2025–integrating genomic medicine into the national healthcare system in France(2025)29 cited
- → Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifestations and high treatment burden(2021)25 cited
- → Chemo-immunotherapy with dinutuximab beta in patients with relapsed/progressive high-risk neuroblastoma: does chemotherapy backbone matter?(2024)23 cited
- → DOCK11 deficiency in patients with X-linked actinopathy and autoimmunity(2023)21 cited
- → Intravenous immunoglobulin–associated thrombosis: is it such a rare event? Report of a pediatric case and of the Quebec Hemovigilance System(2014)21 cited
- → Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma(2024)18 cited
- → Measuring Safety and Outcomes for the Use of Compassionate and Off-Label Therapies for Children, Adolescents, and Young Adults With Cancer in the SACHA-France Study(2023)18 cited
- → Impact of age at diagnosis, sex, and immunopathological manifestations in 886 patients with pediatric chronic immune thrombocytopenia(2023)14 cited